Rosenfeld David M, Knapp Kathleen E, Spiro Joshua A, Gorlin Andrew W, Ramakrishna Harish, Trentman Terrence L
Department of Anesthesiology and Perioperative Medicine, Mayo Clinic Arizona, Phoenix, Arizona, USA.
J Anaesthesiol Clin Pharmacol. 2018 Oct-Dec;34(4):513-517. doi: 10.4103/joacp.JOACP_17_18.
There are limited data on the effect of ampule size on drug dosing. The objective of this study is to determine the effect of ampule size on perioperative opioid dosing and post-anesthesia care unit (PACU) outcomes.
This was a retrospective review of patients undergoing robotically assisted laparoscopic radical prostatectomy before and after a 5-ml fentanyl ampule was discontinued. The primary outcome was intraoperative opioid administration divided into fentanyl at induction of anesthesia, total fentanyl, and total opioid. Secondary outcomes observed in PACU included the opioid administered, visual analog scale (VAS) pain scores, postoperative nausea and vomiting, and length of stay in PACU.
A total of 100 patients (50 PRE and 50 POST) were included. In the intraoperative opioid administration, mean (SD) of fentanyl at induction was 117.0 (49.3) in PRE group and 85.0 (35.4) μg in POST group ( < 0.01). The total fentanyl requirement was 247.0 (31.0) in PRE group and 158.5 (85.1) μg in POST group ( < 0.01). The total opioid in intravenous morphine equivalents (IVME) was 34.1 (5.8) in PRE group and 23.2 (6.8) mg in POST group ( < 0.01). Among the secondary outcomes, mean (SD) of IVME of opioid was 7.7 (8.2) in PRE group and 9.9 (8.1) mg in POST group ( = 0.18). The VAS pain score on arrival was 0.7 (1.4) in PRE group and 3.8 (3.3) in POST group ( < 0.01). The cumulative VAS pain score was 2.3 (2.0) in PRE group and 3.3 (2.2) in POST group ( < 0.01). The length of stay was significantly more in POST group, 193.8 (75.8) minutes, as compared with PRE group, 138.6 (61.0) minutes ( < 0.01).
A change in the ampule size significantly affected intraoperative dosing, PACU pain scores, and PACU length of stay in patients undergoing robotically assisted laparoscopic radical prostatectomy under general anesthesia. This was explained by clinician's desire to conserve the drug and avoid the complex process of narcotic waste disposal.
关于安瓿瓶大小对药物剂量影响的数据有限。本研究的目的是确定安瓿瓶大小对围手术期阿片类药物剂量及麻醉后恢复室(PACU)结局的影响。
这是一项对在停用5毫升芬太尼安瓿瓶前后接受机器人辅助腹腔镜根治性前列腺切除术患者的回顾性研究。主要结局是术中阿片类药物的使用,分为麻醉诱导时的芬太尼、芬太尼总量和阿片类药物总量。在PACU观察的次要结局包括使用的阿片类药物、视觉模拟评分(VAS)疼痛评分、术后恶心呕吐以及在PACU的停留时间。
共纳入100例患者(50例术前和50例术后)。在术中阿片类药物使用方面,术前组麻醉诱导时芬太尼的平均(标准差)剂量为117.0(49.3)微克,术后组为85.0(35.4)微克(P<0.01)。术前组芬太尼总需求量为247.0(31.0)微克,术后组为158.5(85.1)微克(P<0.01)。以静脉注射吗啡当量(IVME)计算的阿片类药物总量,术前组为34.1(5.8)毫克,术后组为23.2(6.8)毫克(P<0.01)。在次要结局中,术前组阿片类药物IVME的平均(标准差)剂量为7.7(8.2)毫克,术后组为9.9(8.1)毫克(P = 0.18)。到达时的VAS疼痛评分,术前组为0.7(1.4),术后组为3.8(3.3)(P<0.01)。累积VAS疼痛评分,术前组为2.3(2.0),术后组为3.3(2.2)(P<0.01)。术后组的停留时间明显更长,为193.8(75.8)分钟,而术前组为138.6(61.0)分钟(P<0.01)。
安瓿瓶大小的改变显著影响了接受全身麻醉下机器人辅助腹腔镜根治性前列腺切除术患者的术中剂量、PACU疼痛评分及PACU停留时间。这可以用临床医生节约药物并避免复杂的麻醉废物处理过程的愿望来解释。